CONMED posts Q3 2026 results, beats adjusted EPS and lifts full‑year EPS guidance
CONMED Corporation reported third‑quarter 2026 net sales of $335.6 million, a 0.7% year‑over‑year decline on a reported basis and a 0.8% decline on a constant‑currency basis. Adjusted diluted earnings per share were $1.04, a 3.2% YoY drop but $0.04 above analyst estimates. The company raised its full‑year 2026 adjusted EPS outlook to $4.54‑$4.61 and narrowed its net‑sales guidance to $1.36‑$1.37 billion, citing strong performance of its AirSeal and Buffalo Filter platforms.
Why it matters
The EPS beat and higher FY EPS range suggest stronger profitability than analysts expected, which could support the stock price. The tighter sales guidance narrows the revenue outlook, giving investors a clearer target for the year.
Key facts
- 1Third‑quarter 2026 net sales were $335.6 million, down 0.7% YoY on a reported basis and down 0.8% on a constant‑currency basis. sec.gov
- 2Adjusted diluted EPS for the quarter was $1.04, down 3.2% YoY. sec.gov
- 3Adjusted EPS of $1.04 beat analyst estimates by $0.04. seekingalpha.com
- 4GAAP diluted EPS was $0.66, up 613.7% YoY. sec.gov
- 5Organic constant‑currency net sales grew 6.7% YoY. sec.gov
- 6Full‑year 2026 adjusted EPS guidance was raised to $4.54‑$4.61. tradingview.com
Summary written by AlphAI AI Desk from 13 of 13 sources. Not investment advice. Figures are as stated by the linked sources.